Dr. Gyamfi-Bannerman is Chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego Health, joining the faculty at UCSD after 16 years on faculty at Columbia University in New York.  She also holds the Samuel SC Yen Endowed Chair at UCSD and is a Professor with Tenure.  She is board certified in both Obstetrics & Gynecology and Maternal-Fetal Medicine and focuses her career on obstetric complications with a primary focus on preterm birth prevention.  Dr. Gyamfi is a proficient, NIH funded researcher whose research has focused on preterm birth prediction and prevention and in interventions to improve outcomes for those delivering preterm, namely antenatal corticosteroids.  Results of her randomized clinical trial on antenatal corticosteroids in women at risk for late preterm birth were published in the New England Journal of Medicine and changed obstetric practice in the United States as evidenced by a change in societal guidelines, leading to a decrease in late preterm respiratory morbidity nationwide as demonstrated by birth certificate data and published in JAMA. 

She also conducts research in the areas of preeclampsia, infectious disease, maternal morbidity and health disparities with over 200 peer-reviewed publications.  She is the Steering Committee Chair of a multi-center NIH study focused on improving maternal outcomes for pregnant individuals from poorly resources backgrounds, and she was selected as a member of the NICHD Council.  Recently, she was elected to the American Society for Clinical Investigation, a national medical honor society.

Aside from her clinical and research endeavors, Dr. Gyamfi is President-Elect for the Society for Maternal-Fetal Medicine (SMFM), the national and international society representing all perinatologists and will become the President in February of 2024.  She is actively involved in writing clinical guidelines in obstetrics for both SMFM and the American College of Obstetricians and Gynecologists.